|
1.Agrawal, R., Sharma, S., Bekir, J., Conway, G., Bailey, J., Balen, A. H., & Prelevic, G. (2004). Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women. Fertil Steril, 82(5), 1352-1357. doi: 10.1016/j.fertnstert.2004.04.041 2.Ayala, C., Steinberger, E., Smith, K. D., Rodriguez-Rigau, L. J., & Petak, S. M. (1999). Serum testosterone levels and reference ranges in reproductive-age women. Endocr Pract, 5(6), 322-329. doi: 10.4158/EP.5.6.322 3.Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., . . . Androgen Excess, S. (2006). Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab, 91(11), 4237-4245. doi: 10.1210/jc.2006-0178 4.Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P. (2005). Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab, 90(8), 4650-4658. doi: 10.1210/jc.2005-0628 5.Balen, A. H., Laven, J. S., Tan, S. L., & Dewailly, D. (2003). Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update, 9(6), 505-514. 6.Barber, T. M., McCarthy, M. I., Wass, J. A., & Franks, S. (2006). Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf), 65(2), 137-145. doi: 10.1111/j.1365-2265.2006.02587.x 7.Barefoot, J. C., Brummett, B. H., Clapp-Channing, N. E., Siegler, I. C., Vitaliano, P. P., Williams, R. B., & Mark, D. B. (2000). Moderators of the effect of social support on depressive symptoms in cardiac patients. Am J Cardiol, 86(4), 438-442. 8.Boehmer, U., & Bowen, D. J. (2009). Examining factors linked to overweight and obesity in women of different sexual orientations. Prev Med, 48(4), 357-361. doi: 10.1016/j.ypmed.2009.02.003 9.Broekmans, F. J., Knauff, E. A., Valkenburg, O., Laven, J. S., Eijkemans, M. J., & Fauser, B. C. (2006). PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG, 113(10), 1210-1217. doi: 10.1111/j.1471-0528.2006.01008.x 10.Carmina, E., Koyama, T., Chang, L., Stanczyk, F. Z., & Lobo, R. A. (1992). Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol, 167(6), 1807-1812. 11.Chen, X., Yang, D., Li, L., Feng, S., & Wang, L. (2006). Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod, 21(8), 2027-2032. doi: 10.1093/humrep/del142 12.De Sutter, P., Dutre, T., Vanden Meerschaut, F., Stuyver, I., Van Maele, G., & Dhont, M. (2008). PCOS in lesbian and heterosexual women treated with artificial donor insemination. Reprod Biomed Online, 17(3), 398-402. 13.DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. (1975). Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol, 121(4), 496-500. 14.Dunaif, A. (1997). Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev, 18(6), 774-800. doi: 10.1210/edrv.18.6.0318 15.Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., Ghazzi, M. N., & Group, P. C. T. S. (2006). Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 91(1), 48-53. doi: 10.1210/jc.2005-1329 16.Esposito, K., Ciotola, M., Giugliano, F., Bisogni, C., Schisano, B., Autorino, R., . . . Giugliano, D. (2007). Association of body weight with sexual function in women. International Journal of Impotence Research, 19(4), 353-357. doi: DOI 10.1038/sj.ijir.3901548 17.Ferraresi, S. R., Lara, L. A., Reis, R. M., & Rosa e Silva, A. C. (2013). Changes in sexual function among women with polycystic ovary syndrome: a pilot study. J Sex Med, 10(2), 467-473. doi: 10.1111/jsm.12011 18.Ferriman, D., & Gallwey, J. D. (1961). Clinical assessment of body hair growth in women. J Clin Endocrinol Metab, 21, 1440-1447. doi: 10.1210/jcem-21-11-1440 19.Fredriksen-Goldsen, K. I., Kim, H.-J., Barkan, S. E., Muraco, A., & Hoy-Ellis, C. P. (2013). Health Disparities Among Lesbian, Gay, and Bisexual Older Adults: Results From a Population-Based Study. American Journal of Public Health, 103(10), 1802-1809. doi: 10.2105/AJPH.2012.301110 20.Gartrell, N. K., Loriaux, D. L., & Chase, T. N. (1977). Plasma testosterone in homosexual and heterosexual women. Am J Psychiatry, 134(10), 1117-1118. 21.Hsu, M. I. (2013). Changes in the PCOS phenotype with age. Steroids, 78(8), 761-766. doi: 10.1016/j.steroids.2013.04.005 22.Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011). Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome. Fertil Steril, 96(4), 1043-1047. doi: 10.1016/j.fertnstert.2011.07.002 23.Ibricevic, D., & Asimi, Z. V. (2013). Frequency of prediabetes in women with polycystic ovary syndrome. Med Arh, 67(4), 282-285. 24.Kulshreshtha, B., Singh, S., & Arora, A. (2013). Family background of Diabetes Mellitus, obesity and hypertension affects the phenotype and first symptom of patients with PCOS. Gynecol Endocrinol, 29(12), 1040-1044. doi: 10.3109/09513590.2013.829446 25.Kumar, A., Woods, K. S., Bartolucci, A. A., & Azziz, R. (2005). Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf), 62(6), 644-649. doi: 10.1111/j.1365-2265.2005.02256.x 26.Lauritsen, M. P., Bentzen, J. G., Pinborg, A., Loft, A., Forman, J. L., Thuesen, L. L., . . . Nyboe Andersen, A. (2014). The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod, 29(4), 791-801. doi: 10.1093/humrep/det469 27.Liang, S. J., Hsu, C. S., Tzeng, C. R., Chen, C. H., & Hsu, M. I. (2011). Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod, 26(12), 3443-3449. doi: 10.1093/humrep/der302 28.Liou, T. H., Yang, J. H., Hsieh, C. H., Lee, C. Y., Hsu, C. S., & Hsu, M. I. (2009). Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril, 92(6), 1960-1965. doi: 10.1016/j.fertnstert.2008.09.003 29.Lord, J. M., Flight, I. H., & Norman, R. J. (2003). Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ, 327(7421), 951-953. doi: 10.1136/bmj.327.7421.951 30.Mansson, M., Norstrom, K., Holte, J., Landin-Wilhelmsen, K., Dahlgren, E., & Landen, M. (2011). Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. Eur J Obstet Gynecol Reprod Biol, 155(2), 161-165. doi: 10.1016/j.ejogrb.2010.12.012 31.Miller, K. K., Rosner, W., Lee, H., Hier, J., Sesmilo, G., Schoenfeld, D., . . . Klibanski, A. (2004). Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab, 89(2), 525-533. doi: 10.1210/jc.2003-030680 32.Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., . . . Muggeo, M. (2000). Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab, 85(1), 139-146. doi: 10.1210/jcem.85.1.6293 33.Monga, M., Alexandrescu, B., Katz, S. E., Stein, M., & Ganiats, T. (2004). Impact of infertility on quality of life, marital adjustment, and sexual function. Urology, 63(1), 126-130. 34.Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007). Polycystic ovary syndrome. Lancet, 370(9588), 685-697. doi: 10.1016/S0140-6736(07)61345-2 35.Norman, R. J., Masters, S., & Hague, W. (1996). Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Steril, 66(6), 942-947. 36.Pigny, P., Jonard, S., Robert, Y., & Dewailly, D. (2006). Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab, 91(3), 941-945. doi: 10.1210/jc.2005-2076 37.Rellini, A. H., Stratton, N., Tonani, S., Santamaria, V., Brambilla, E., & Nappi, R. E. (2013). Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome. Horm Behav, 63(1), 65-71. doi: 10.1016/j.yhbeh.2012.10.013 38.Rotterdam, E. A.-S. P. C. W. G. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 81(1), 19-25. 39.Salley, K. E., Wickham, E. P., Cheang, K. I., Essah, P. A., Karjane, N. W., & Nestler, J. E. (2007). Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab, 92(12), 4546-4556. doi: 10.1210/jc.2007-1549 40.Smith, H. A., Markovic, N., Matthews, A. K., Danielson, M. E., Kalro, B. N., Youk, A. O., & Talbott, E. O. (2011). A comparison of polycystic ovary syndrome and related factors between lesbian and heterosexual women. Womens Health Issues, 21(3), 191-198. doi: 10.1016/j.whi.2010.11.001 41.Somani, N., & Turvy, D. (2014). Hirsutism: an evidence-based treatment update. Am J Clin Dermatol, 15(3), 247-266. doi: 10.1007/s40257-014-0078-4 42.Stovall, D. W., Scriver, J. L., Clayton, A. H., Williams, C. D., & Pastore, L. M. (2012). Sexual function in women with polycystic ovary syndrome. J Sex Med, 9(1), 224-230. doi: 10.1111/j.1743-6109.2011.02539.x 43.Vrbikova, J., Grimmichova, T., Dvorakova, K., Hill, M., Stanicka, S., & Vondra, K. (2008). Family history of diabetes mellitus determines insulin sensitivity and beta cell function in polycystic ovary syndrome. Physiol Res, 57(4), 547-553. 44.Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., . . . Dumesic, D. A. (2010). Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab, 95(5), 2038-2049. doi: 10.1210/jc.2009-2724 45.Zegers-Hochschild, F., Adamson, G. D., de Mouzon, J., Ishihara, O., Mansour, R., Nygren, K., . . . World Health, O. (2009). The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod, 24(11), 2683-2687. doi: 10.1093/humrep/dep343
|